Casdin Capital

Casdin Capital as of Dec. 31, 2018

Portfolio Holdings for Casdin Capital

Casdin Capital holds 31 positions in its portfolio as reported in the December 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Loxo Oncology 8.6 $50M 360k 140.07
Myokardia 6.6 $39M 790k 48.86
Blueprint Medicines (BPMC) 5.9 $35M 640k 53.91
Codexis (CDXS) 5.8 $34M 2.0M 16.70
Spark Therapeutics 5.6 $33M 840k 39.14
Bluebird Bio (BLUE) 5.6 $33M 330k 99.20
Fate Therapeutics (FATE) 5.6 $33M 2.6M 12.83
Sage Therapeutics (SAGE) 5.1 $30M 312k 95.79
Biolife Solutions (BLFS) 5.0 $29M 2.4M 12.03
Invitae (NVTAQ) 4.5 $27M 2.4M 11.06
Alnylam Pharmaceuticals (ALNY) 4.4 $26M 355k 72.91
Agios Pharmaceuticals (AGIO) 3.5 $21M 445k 46.11
GenMark Diagnostics 3.2 $19M 3.8M 4.86
Audentes Therapeutics 3.1 $18M 860k 21.32
Illumina (ILMN) 3.1 $18M 60k 299.93
Sarepta Therapeutics (SRPT) 2.8 $16M 150k 109.13
Magenta Therapeutics 2.6 $15M 2.6M 5.70
Global Blood Therapeutics In 2.5 $14M 350k 41.05
Sangamo Biosciences (SGMO) 2.1 $12M 1.1M 11.48
Gritstone Oncology Ord (GRTS) 1.9 $11M 721k 15.45
Evolent Health (EVH) 1.9 $11M 550k 19.95
Editas Medicine (EDIT) 1.9 $11M 480k 22.75
Voyager Therapeutics (VYGR) 1.8 $11M 1.1M 9.40
Beigene (BGNE) 1.7 $9.8M 70k 140.26
Homology Medicines 1.3 $7.8M 350k 22.36
Constellation Pharmceticls I 1.1 $6.2M 1.6M 4.01
iShares NASDAQ Biotechnology Index (IBB) 1.0 $5.8M 60k 96.43
Caredx (CDNA) 0.9 $5.0M 200k 25.14
Denali Therapeutics (DNLI) 0.3 $2.1M 100k 20.66
Quotient 0.3 $2.0M 325k 6.12
Neon Therapeutics 0.2 $1.3M 263k 5.03